Published in JAMA Neurology · View the paper (DOI)
Researchers investigated low-dose lithium as a potential treatment for mild cognitive impairment in a pilot clinical trial. The study found that none of the primary outcomes met the significance threshold, but effect size estimates suggest potential benefits for future trials.
Coverage from 2 institutions
- Low-dose lithium for mild cognitive impairment JAMA Network · Mar 2, 2026 · first to report
- Pilot clinical trial suggests low dose lithium may slow verbal memory decline University of Pittsburgh · Mar 2, 2026